REFRACTORY CUTANEOUS MELANOMA

Clinical trials for REFRACTORY CUTANEOUS MELANOMA explained in plain language.

Never miss a new study

Get alerted when new REFRACTORY CUTANEOUS MELANOMA trials appear

Sign up with your email to follow new studies for REFRACTORY CUTANEOUS MELANOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Terminated 1

Donor immune cells tested as new weapon against tough childhood cancers

Disease control Terminated

This early-stage study tested a new combination treatment for children and young adults whose solid tumors had returned or stopped responding to standard therapies. Researchers gave patients chemotherapy followed by immune cells (called NK cells) donated from umbilical cord blood…

Matched conditions: REFRACTORY CUTANEOUS MELANOMA

Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control

Last updated Apr 02, 2026 14:57 UTC

REFRACTORY CUTANEOUS MELANOMA

Get alerted when new REFRACTORY CUTANEOUS MELANOMA trials appear

Donor immune cells tested as new weapon against tough childhood cancers